Gary Blackford's SEC Filing Summary

This filing details a transaction by Gary Blackford, a director at AVANOS MEDICAL, INC. (AVNS). On May 8, 2026, Blackford was issued 12,003 Restricted Share Units (RSUs), replacing previously issued RSUs. These RSUs represent a contingent right to receive a cash payment equivalent to the value of one share of AVNS common stock. The RSUs are set to vest upon Blackford's termination of service on the Issuer's Board of Directors. The transaction is classified as an acquisition (Code 'A') with a transaction price of $0.0 per share. Following this transaction, Blackford holds 12,003 RSUs.